• Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 05 Feb 2025 03:31:09   America/New_York


    Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 5, 2025 Share Link copied to clipboard. Nurix Therapeutics, Inc. ( NASDAQ:NRIX - Get Free Report ) has rec
    Read more...
Share on,